Psychiatry and Neurology, Neurology · Charleston, SC
NPI
1558526947
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
703 services
Medicare patients, 2024
298
Average age 73
Drug cost, 2024
$3.3M
506 prescriptions
Company payments, 2025
$2,211
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katherine Ruzhansky was code 95886 (electrical nerve conductivity), 102 times for 93 patients. In total Katherine Ruzhansky billed 703 services in 22 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Facility | 102 | 93 | $33.35 | $3,402 |
| 95885 Electrical Nerve Conductivity | Facility | 86 | 81 | $12.33 | $1,061 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 66 | 53 | $12.12 | $800 |
| 95911 Electrical Nerve Conductivity | Facility | 56 | 56 | $86.25 | $4,830 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 48 | 37 | $11.83 | $568 |
| 99215 Office E&M - Established | Facility | 47 | 38 | $102.09 | $4,798 |
| 99205 Office E&M - New | Office | 45 | 45 | $132.10 | $5,944 |
| 99215 Office E&M - Established | Office | 35 | 34 | $120.00 | $4,200 |
| 99214 Office E&M - Established | Office | 35 | 33 | $87.50 | $3,062 |
| 95913 Electrical Nerve Conductivity | Facility | 34 | 34 | $132.25 | $4,497 |
| 95912 Electrical Nerve Conductivity | Facility | 34 | 34 | $110.84 | $3,768 |
| 99214 Office E&M - Established | Facility | 20 | 19 | $60.00 | $1,200 |
| 95910 Electrical Nerve Conductivity | Facility | 17 | 17 | $66.65 | $1,133 |
| 99205 Office E&M - New | Facility | 17 | 17 | $127.54 | $2,168 |
| 95908 Electrical Nerve Conductivity | Facility | 14 | 14 | $48.94 | $685 |
By year: 2022 $59K for 814 services; 2023 $40K for 540 services; 2024 $45K for 703 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katherine Ruzhansky prescribed most often to Medicare patients was Pyridostigmine Bromide, with 65 prescriptions and refills. In total Katherine Ruzhansky wrote 506 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pyridostigmine Bromide Generic | 65 | 122 | 20 | $4,249 |
| Prednisone Generic | 65 | 88 | 16 | $385 |
| Mycophenolate Mofetil Generic | 65 | 108 | 13 | $6,754 |
| Riluzole Generic | 41 | 49 | 14 | $4,708 |
| Azathioprine Generic | 32 | 56 | Under 11 | $1,524 |
| Radicava Ors Edaravone | 31 | 31 | Under 11 | $435K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 28 | 28 | Under 11 | $134K |
| Sodium Chloride Sodium Chloride 0.45 % | 17 | 17 | Under 11 | $172 |
| Zilbrysq Zilucoplan Sodium | 15 | 15 | Under 11 | $641K |
| Baclofen Generic | 14 | 18 | Under 11 | $207 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 14 | 14 | Under 11 | $235K |
| Levetiracetam Generic | 12 | 12 | Under 11 | $288 |
| Emflaza Deflazacort | 12 | 12 | Under 11 | $66K |
| Gabapentin Generic | 11 | 17 | Under 11 | $279 |
Brand drugs: - claims; generic drugs: 333 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Katherine Ruzhansky $2,211 ($2,211 in general payments such as food, travel and fees) from 6 companies. The largest payer was UCB, Inc. with $1,508.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.